(Q41605611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Autoantibodies against oxidized LDL. A potential marker for atherosclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

Wu JT

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Wu LL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

Clinics in laboratory medicine

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

595-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Isolation and characterization of human antioxidized LDL autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Monoclonal antibody-based immunoassay for evaluation of lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930213-0

7 January 2021

10.1016/S0272-2712(18)30213-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316776%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference